We are live on ! Find out more
EIDX

Eidos Therapeutics, Inc. Common Stock
EIDX

Delisted

EIDX was delisted on the 25th of January, 2021.

Back to rankings

45 hedge funds and large institutions have $174M invested in Eidos Therapeutics, Inc. Common Stock in 2018 Q2 according to their latest regulatory filings, with 45 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
45
Holders Change
+45
Holders Change %
–
% of All Funds
1.03%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
45
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
RCM
RA Capital Management
Massachusetts
+$45.3M
2
Viking Global Investors
Viking Global Investors
Connecticut
+$41.6M
3
PA
Perceptive Advisors
New York
+$14.4M
4
CAM
Cormorant Asset Management
Massachusetts
+$8.09M
5
DM
Deerfield Management
New York
+$6.79M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
RCM
1
RA Capital Management
Massachusetts
$44M +$45.3M +2,162,671 New
Viking Global Investors
2
Viking Global Investors
Connecticut
$40.4M +$41.6M +1,986,201 New
PA
3
Perceptive Advisors
New York
$14M +$14.4M +686,922 New
CAM
4
Cormorant Asset Management
Massachusetts
$7.46M +$8.09M +385,846 New
DM
5
Deerfield Management
New York
$6.59M +$6.79M +323,807 New
Janus Henderson Group
6
Janus Henderson Group
United Kingdom
$6.51M +$6.71M +320,121 New
Millennium Management
7
Millennium Management
New York
$5.71M +$5.88M +280,469 New
FCMI
8
Foresite Capital Management IV
California
$4.99M +$5.14M +245,082 New
HIM
9
Hillhouse Investment Management
Cayman Islands
$4.58M +$4.72M +225,000 New
MWNA
10
Marshall Wace North America
New York
$4.31M +$4.44M +211,979 New
Point72 Asset Management
11
Point72 Asset Management
Connecticut
$4.1M +$4.23M +201,780 New
RG
12
Redmile Group
California
$3.88M +$4M +191,000 New
BOTOTLSJU
13
Board of Trustees of The Leland Stanford Junior University
California
$3.64M +$3.75M +179,072 New
EAM
14
Eventide Asset Management
Massachusetts
$3.29M +$3.4M +162,000 New
BlackRock
15
BlackRock
New York
$3.05M +$3.14M +150,000 New
OAM
16
Oxford Asset Management
United Kingdom
$2.85M +$2.99M +142,788 New
MIM
17
Monashee Investment Management
Massachusetts
$2.54M – – –
Balyasny Asset Management
18
Balyasny Asset Management
Illinois
$1.64M +$1.69M +80,600 New
Wellington Management Group
19
Wellington Management Group
Massachusetts
$1.24M +$1.28M +60,936 New
LCM
20
Laurion Capital Management
New York
$1.02M +$1.05M +50,000 New
Vanguard Group
21
Vanguard Group
Pennsylvania
$1.02M +$1.05M +50,000 New
WAM
22
Wolverine Asset Management
Illinois
$1.02M +$1.05M +50,000 New
SM
23
Sabby Management
Florida
$1.01M +$1.04M +49,833 New
Citadel Advisors
24
Citadel Advisors
Florida
$874K +$901K +42,960 New
Goldman Sachs
25
Goldman Sachs
New York
$645K +$664K +31,692 New
1
2

EIDX Hedge Fund Activity: Q2 2018 in Review

45 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Eidos Therapeutics, Inc. Common Stock (EIDX) for Q2 2018, worth a combined $174M.

Buyers outnumbered sellers: 45 funds opened new EIDX positions and 0 closed out — a net gain of 45 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was RA Capital Management, opening a new position worth an estimated $45.3M.

  • 45 institutional investors held Eidos Therapeutics, Inc. Common Stock (EIDX) as of Q2 2018, up from 0 in Q1 2018.
  • Funds reported $174M of Eidos Therapeutics, Inc. Common Stock stock for Q2 2018.
  • 45 funds opened new Eidos Therapeutics, Inc. Common Stock positions in Q2 2018 and 0 closed out, a net change of +45 holders.
  • The largest Eidos Therapeutics, Inc. Common Stock buyer in Q2 2018 was RA Capital Management, an estimated $45.3M added.

Based on aggregated 13F filings for Q2 2018.